West Pharmaceutical Services

101 Gordon Drive
Lionville
Pennsylvania
19341
United States

Tel: 610-594-2900
Fax: 610-594-3000

Show jobs for this employer

242 articles with West Pharmaceutical Services

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate Secretary, effective December 8, 2020.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per share, a 6.25% increase over the $0.16 per share declared for each of the four preceding quarters.

  • Universal, needle-free admixture device for immediate use IV administration designed to maximize the benefits of point-of-care nursing

  • West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release third-quarter 2020 financial results before the market opens on Thursday, October 22, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the Company's Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P® 500, which will become effective after close of trading .

  • West Pharmaceutical Services, Inc. announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May 14, 2020, as well as the Jeffries Virtual Healthcare Conference 2020 on Tuesday, June 2, 2020.

  • - Conference Call Scheduled for 9 a.m. EDT Today -

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19 pandemic and restrictions issued by the Commonwealth of Pennsylvania and the Center for Disease Control.

  • West Pharmaceutical Services, Inc. announced that it will release first-quarter 2020 financial results before the market opens on Thursday, April 23, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the Company's Board of Directors has elected Robert Friel as its newest member.

  • West Pharmaceutical Services, Inc. announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.

  • AccelTRA® Component Line Extensions, New Container Closure System and Ready Pack™ System Featuring SCHOTT iQ® Platform Bring Greater Value to Global Customers, Advance West Industry Leadership

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on Thursday, February 13, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Business Daily.

  • West Pharmaceutical Services, Inc. announced that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.

  • West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in London, United Kingdom on Wednesday, November 20, 2019.